 Durham, North Carolina -- Medical device technology company BioMedomics has received $276,000 in venture capital equity funding, according to an SEC regulatory filing.
BioMedomics says that is developing highly sensitive, rapid, point of care diagnostic platforms.
The diagnostics are focused on its areas of expertise: drugs of abuse/overdose and hemoglobinopathies.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
BioMedomics is still seeking $1.2 million in additional equity financing, according to the filing. |